Biojo Sciences is a global biopharmaceutical company that develops novel clinical-stage therapies to improve patient and family lives. Our efficient development process identifies and delivers compelling clinical-stage biotechnologies through effective operations in an innovative portfolio biotech company. We bring clinical-stage drug assets to commercialization through licensing and partnerships. Our team has deep industry knowledge of the latest science, regulatory pathways, and business strategies. Our portfolio targets a diverse range of diseases and technologies, including oncology, neurology, rare diseases, and cell & gene platforms.
Our mission at Biojo Sciences is to focus on creating therapeutic value for patients, for innovative science, and for our stakeholders.
Jenny (Seungyun) Jo
Founder & CEO